Stock Scorecard



Stock Summary for Simulations Plus Inc (SLP) - $20.00 as of 1/20/2026 6:39:20 PM EST

Total Score

11 out of 30

Safety Score

20 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for SLP

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SLP

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SLP

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SLP

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SLP (20 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 1
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for SLP

Johnson Fistel Investigates Simulations Plus for Potential Securities Law Violations 1/20/2026 2:57:00 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP 1/18/2026 11:57:00 PM
ROSEN, LEADING INVESTOR COUNSEL, Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP 1/18/2026 8:28:00 PM
Stephens Investment Management Group LLC Buys 124,264 Shares of Simulations Plus, Inc. $SLP 1/18/2026 12:10:00 PM
Simulations Plus, Inc. (NASDAQ:SLP) Given Average Rating of "Hold" by Brokerages 1/17/2026 6:57:00 AM
Simulations Plus (NASDAQ:SLP) shareholders are up 12% this past week, but still in the red over the last five years 1/16/2026 9:59:00 AM
Simulations Plus (SLP) Upgraded to Strong Buy: Here's What You Should Know 1/11/2026 12:57:00 AM
Simulations Plus, Inc. SEC 10-Q Report 1/9/2026 9:11:00 PM
Simulations Plus: Fiscal Q1 Earnings Snapshot 1/9/2026 3:11:00 PM
Simulations Plus Q1 Earnings Call Highlights 1/9/2026 12:57:00 PM

Financial Details for SLP

Company Overview

Ticker SLP
Company Name Simulations Plus Inc
Country N/A
Description Simulations Plus, Inc. (SLP) is a premier provider of advanced software solutions tailored for drug discovery and development, focusing on mechanistic modeling, simulation, and predictive analysis of molecular properties. By leveraging state-of-the-art artificial intelligence and machine learning technologies, the company caters to the global pharmaceutical and biotechnology sectors, significantly improving the efficiency of drug development processes. With its headquarters in Lancaster, California, Simulations Plus is strategically positioned to capitalize on the growing need for innovative tools that enhance research outcomes in drug development, making it a key player in the life sciences technology landscape.
Sector Name HEALTHCARE
Industry Name HEALTH INFORMATION SERVICES
Most Recent Quarter 11/30/2025
Next Earnings Date 4/8/2026

Stock Price History

Last Day Price 20.00
Price 4 Years Ago 36.20
Last Day Price Updated 1/20/2026 6:39:20 PM EST
Last Day Volume 267,751
Average Daily Volume 319,420
52-Week High 37.67
52-Week Low 12.39
Last Price to 52 Week Low 61.42%

Valuation Measures

Trailing PE N/A
Industry PE 289.22
Sector PE 134.30
5-Year Average PE 81.98
Free Cash Flow Ratio 13.33
Industry Free Cash Flow Ratio 21.16
Sector Free Cash Flow Ratio 24.90
Current Ratio Most Recent Quarter 5.62
Total Cash Per Share 1.50
Book Value Per Share Most Recent Quarter 6.31
Price to Book Ratio 3.21
Industry Price to Book Ratio 3.27
Sector Price to Book Ratio 8.78
Price to Sales Ratio Twelve Trailing Months 5.19
Industry Price to Sales Ratio Twelve Trailing Months 4.67
Sector Price to Sales Ratio Twelve Trailing Months 27.11
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 20,146,600
Market Capitalization 402,932,000
Institutional Ownership N/A

Dividends

Ex-Dividend Date 7/29/2024
Previous Dividend Amount 0.0600
Current Dividend Amount 0.0600
Total Years Dividend Increasing 0
Trailing Annual Dividend Rate 0.24
Trailing Annual Dividend Yield 1.83%
Forward Annual Dividend Rate 0.24
Forward Annual Dividend Yield 1.83%
5-Year Dividend Payments Count 16
3-Year Average Dividend Yield 0.60%
5-Year Average Dividend Yield 0.51%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage -3.42%
Dividend Payout Ratio -7.62%

Income Statement

Quarterly Earnings Growth YOY 200.00%
Annual Earnings Growth -750.17%
Reported EPS 12 Trailing Months -3.20
Reported EPS Past Year 0.10
Reported EPS Prior Year -2.77
Net Income Twelve Trailing Months -64,248,000
Net Income Past Year -64,718,000
Net Income Prior Year 9,954,000
Quarterly Revenue Growth YOY -2.70%
5-Year Revenue Growth 13.74%
Operating Margin Twelve Trailing Months 3.87%

Balance Sheet

Total Cash Most Recent Quarter 30,189,000
Total Cash Past Year 30,853,000
Total Cash Prior Year 10,311,000
Net Cash Position Most Recent Quarter 30,189,000
Net Cash Position Past Year 30,853,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 124,801,000
Total Stockholder Equity Prior Year 182,431,000
Total Stockholder Equity Most Recent Quarter 127,113,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 22,216,000
Free Cash Flow Per Share Twelve Trailing Months 1.10
Free Cash Flow Past Year 17,413,000
Free Cash Flow Prior Year 12,754,000

Options

Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 1.10
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 37.20

System

Modified 1/20/2026 8:18:48 AM EST